Navigation Links
K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common Stock
Date:2/14/2011

ST. LOUIS, Mo., Feb. 14, 2011 /PRNewswire/ -- K-V Pharmaceutical Company (NYSE:  KVa/KVb) (the "Company") today announced that it has entered into a definitive agreement with a group of institutional investors to raise approximately $32 million of gross proceeds from a private placement of 9,950,000 shares of its Class A Common Stock at $3.25 per share. The Company will use $20 million of the proceeds from the financing to repay certain outstanding amounts and other outstanding obligations under its credit agreement with U.S. Healthcare and the remainder for general corporate purposes, including the launch of Makena™. Subject to the satisfaction of customary closing conditions, the private placement is expected to close and fund on or about February 17, 2011.  

The Company also announced it has agreed to terms with US Healthcare I, L.L.C. and US Healthcare II, L.L.C., affiliates of New York based Centerbridge Partners, L.P. to close on a multi-draw financing facility with a total commitment of $130 million. The amendment is expected to be completed on or prior to February 18, 2011.  In addition, the Company has agreed to issue additional warrants to purchase 7,450,899 shares of the Company's Class A Common Stock, subject to completion of the private placement, at an exercise price of $1.62 per share.

Upon completion of the definitive agreement, the loan terms and covenants will be amended to reflect the Company's current projections and timing of certain anticipated future events, including the planned disposition of certain assets.  The significant components of the amended agreement will include extending the $60 million payment that was due on March 20, 2011 to three payments of $20 million each with the first payment due upon closing and funding the private placement, $20 million due in April 2011 and $20 million due in August 2011.  In addition, all past covenant issues will be waived.  In addition to the loa
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015 Biopharmaceutical Industry Leads Manufacturing Sector ... out on top as the country,s manufacturing leader in ...  from ndp│analytics. According to the  analysis , the industry ... the last decade, accounting for 27 percent of average ... A Short Video on Medicare Part D - ...
(Date:3/27/2015)... Texas , March 27, 2015 The Temple ... in April to a 5,000-square-foot building at 1802 South First ... geographic area designated by the City of Temple ... Scott & White and the Central Texas Veterans Health Care ... and laboratory space to early stage biotechnology and life science ...
(Date:3/27/2015)... 2015 A new report from Kalorama Information says ... – Chile , Colombia ... for IVD firms.  The healthcare research firm said that while ... for the Latin American continent with a population of over ... operations. However, the country,s regional economic clout does not necessarily ...
Breaking Medicine Technology:Week in Review: The Latest from PhRMA 2Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4
... today announced that this year,s show has already eclipsed last ... Mark Alexay, its President. The annual chemistry and pharmaceutical ingredients ... from Contract Research and Manufacturing organizations. This ... Ocean Place Resort in Long Branch, NJ. ...
... WOODCLIFF LAKE, N. J., Aug. 4, 2011 ... calling for information on fragrance ingredients from the ... ketones. The Expert Panel will review this group ... are: (Logo: http://photos.prnewswire.com/prnh/20101215/DC17717LOGO) ...
Cached Medicine Technology:2011 ChemOutsourcing Record Attendance Marks 5th Year of Uninterrupted Growth of Annual Pharmaceutical Ingredients Show 2Independent Expert Panel Calls for Information on Fragrance Ingredients Under Review 2
(Date:3/29/2015)... March 29, 2015 Final Cut ... transition from Pixel Film Studios, entitled TranSports. , ... exclusively for Final Cut Pro X,” said Christiana Austin, ... the tools needed to effortlessly transition using this cool ... a new and uniquely styled transition pack for Final ...
(Date:3/28/2015)... Tucson, AZ (PRWEB) March 28, 2015 Coffee ... could also help protect you from gum disease, researchers have ... protected against gum disease. , Coffee contains antioxidants. Antioxidants fight ... is the question researchers at Boston Univ. Henry M. Goldman ... published in the August 2014 issue of the Journal of ...
(Date:3/28/2015)... MILAN (PRWEB) March 28, 2015 ... thought-leaders in the fields of osteoporosis, osteoarthritis and ... on Osteoporosis, it may be the first time ... educational research forum that the hot-button topic is ... Based on the well-accepted scientific principles of Wolff’s ...
(Date:3/28/2015)... FL (PRWEB) March 28, 2015 ... conditions coverage is made available to all visitors who ... effective immediately. All members are encouraged to purchase the ... to avoid lack of proper coverage for pre-existing medical ... from one or two medical conditions with serious consequences ...
(Date:3/28/2015)... March 28, 2015 One in three ... to research presented today at the American Orthopaedic Society ... study examined the long term success of surgery for ... examined survey data from 242 patients who underwent ACL ... P. Roe, MBBS, FRACS, from North Sydney Orthopaedic and ...
Breaking Medicine News(10 mins):Health News:Introducing TranSports for Final Cut Pro X Users from Pixel Film Studios 2Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2
... a massive public awareness campaign on health and hygiene in ... UN Children's Fund (UNICEF) aims to educate more than two ... of the campaign will begin in Kabul on June 24, ... in following weeks. , ,Each phase lasts 20 days, ...
... wave therapy would cure ailments caused by irregular heartbeats, ... Electrophysiology said here today. // ,Speaking on ... Lifeline Hospital of the Dr K M Cherian Heart ... by irregular heartbeats, was prevalent among 10 per cent ...
... it is a dyslexic's mode of writing where letters in ... dyslexia, has a genetic component, according to German researchers. And ... treatment. , Dyslexia generally affects family groups. Scientists ... located the dyslexia gene, denoted as DCDC2, the presence of ...
... the Grampians Community Health Centre has made people to be ... ,Educating people about the adverse effects of some drugs ... center. ,Problems related to health, social, economical, ... drug misuse in every community. So, in the idea of ...
... some time now, concern has been raised by health authorities ... microbes to become drug resistant, especially to antibiotics //. ... majority of people are already harboring bacteria that are drugs ... of the mutated microorganisms to resist antibiotics is an ever-growing ...
... Boards and Primary Health Organisations, (PHOs), which faced difficulties late ... reaching an agreement on the extension of subsidies for ... GP patients, aged between 45 - 64 years, are expected ... long been at loggerheads over the conditions, with the ...
Cached Medicine News:Health News:Drug - resistant microbes raise concerns 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: